Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat
about
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegenerationSite-specific and time-dependent activation of the endocannabinoid system after transection of long-range projectionsMonoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in miceThe pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivativesSynthesis and pharmacology of 1-methoxy analogs of CP-47,497.1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.Functional disassociation of the central and peripheral fatty acid amide signaling systems.Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems.Cannabinoid receptors and endocannabinoids: evidence for new players.Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathyEffects of palmitoylethanolamide on aqueous humor outflow.Anti-Inflammatory, Antioxidant and Crystallographic Studies of N-Palmitoyl-ethanol Amine (PEA) Derivatives.Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Evaluation of fatty acid amides in the carrageenan-induced paw edema model.Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.Management of itch in atopic dermatitis.The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.Anti-anaphylactic effects of Trichilia monadelpha (Thonn.) J. J. De Wilde extracts on rodent models of anaphylaxis.Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion.Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice.Randomized split-mouth study on postoperative effects of palmitoylethanolamide for impacted lower third molar surgery.Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patientsActivation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamideCharacterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids.Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints.Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.Effect of palmitoylethanolamide on inflammatory and neuropathic pain in ratsInvolvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats.
P2860
Q24651712-7D59DE11-5996-4916-8913-0E6979A02952Q27306768-05F0380A-4615-4156-B67D-D43DDC2296D5Q28534648-E7A543E7-B8C6-458E-9648-24B55DE29124Q31122398-E9C83D6D-12AD-4358-B2FD-029998834A07Q34004234-E95E452C-DBD9-49B2-859E-92057E180641Q34059803-398C6076-C705-47DD-B11B-6EB7D5A61EFDQ34298682-7326390E-2105-45A0-8D20-AC6063961F13Q34332678-942027B6-20FB-48A1-9817-E461B75F52DDQ34772868-A9C904F6-52FF-4F23-9626-F27A06318D39Q34993393-6D397EDE-4006-4E96-8271-64F8C5B77508Q35044663-0223625A-212B-4413-9906-8034AF55D6A8Q35594830-FA0320B8-8F65-4032-8648-9C4C2DB53C50Q36027964-9F6359F3-BF92-44C8-B37A-18AB5A0A0683Q36094329-692810A1-32C0-422E-B345-CB75D2CA9306Q36223797-885F60BA-4FEC-4B42-9CAC-A3453B7849E6Q36343053-6C6E6833-771B-42AF-A7C4-BDB4254BB331Q36348374-8893A414-1B0C-45AD-86B0-A92D94047688Q36384547-141E1CF7-DB7F-40EC-B2A0-4020B9069B7EQ36419669-48615461-D5FA-430E-9828-68A6326AAE3FQ36488601-75B22C55-69AB-4939-A074-F5AA109E6832Q36991444-F20AC83C-B961-4651-9380-EA85ACFC39C9Q37030457-441B650B-FE9F-4FC8-AA64-121BB61C2D8EQ37162136-1E629DB0-211C-4403-834F-762C02FA4C02Q37371095-72702D42-5319-4718-9851-FB16F301C1A4Q37438864-F6BD1094-3728-4C53-A0C6-20B74286EE46Q37595794-746FB795-EBF3-473A-BA7B-FDD68BE81D02Q38087533-618127A6-3C97-4920-AD1E-854C7ADA1E21Q38118187-9CE99A6E-AF83-43A8-B9F1-5E048D324F76Q38157791-42D4AC9B-6F2F-4EAF-8971-0D11C8F22DF6Q38645776-3D9EF244-5145-4A14-BE69-E0E2612CCC47Q38807985-DA5313FD-3FC5-4817-905B-9987720967F1Q38908402-897B420F-CF8E-48D8-8DED-047E1B083DB8Q39256299-586677E7-E078-4D28-B856-87EB6C2E7F57Q41340447-5850DA23-98C5-44E7-AFD5-2D7D75C921EEQ41832173-92CB9A06-D3EA-4BBA-A69C-F797B79CBF34Q41912809-B59FE529-CAD5-44F3-99F4-BAA119416B43Q41983974-752B3E3E-6522-46DA-BBF6-4830D585401EQ42176106-01878154-E08C-4F8E-A414-0E2B4237D3D0Q42379739-CF41081A-4A14-4B7C-8207-965A83CAD6EBQ42501114-1103F973-111A-4BFC-84E4-0A11226A6139
P2860
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antiinflammatory action of end ...... acute inflammation in the rat
@ast
Antiinflammatory action of end ...... acute inflammation in the rat
@en
Antiinflammatory action of end ...... acute inflammation in the rat
@nl
type
label
Antiinflammatory action of end ...... acute inflammation in the rat
@ast
Antiinflammatory action of end ...... acute inflammation in the rat
@en
Antiinflammatory action of end ...... acute inflammation in the rat
@nl
prefLabel
Antiinflammatory action of end ...... acute inflammation in the rat
@ast
Antiinflammatory action of end ...... acute inflammation in the rat
@en
Antiinflammatory action of end ...... acute inflammation in the rat
@nl
P2093
P2860
P921
P3181
P356
P1476
Antiinflammatory action of end ...... acute inflammation in the rat
@en
P2093
Barbara Costa
Daniela Parolaro
Gabriella Giagnoni
Mariapia Colleoni
Silvia Conti
P2860
P3181
P356
10.1038/SJ.BJP.0704466
P407
P577
2002-01-01T00:00:00Z